Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 2,171 | 2,376 | 1,405 | 828 | 7,130 |
| Cost of Goods | 3,754 | 2,511 | 1,587 | 856 | 1,736 |
| Gross Profit | -1,583 | -135 | -182 | -28 | 5,394 |
| Operating Expenses | 12,975 | 9,089 | 8,088 | 6,154 | -1,339 |
| Operating Income | -13,805 | -8,713 | -7,682 | -5,326 | 7,469 |
| Interest Expense | -5 | 15 | 1 | 9 | 15 |
| Other Income | 4,244 | 5,893 | 2,261 | 7,016 | 1,016 |
| Pre-tax Income | -9,556 | -2,835 | -5,422 | 1,681 | 8,470 |
| Income Tax | 1 | 1 | N/A | N/A | -140 |
| Net Income Continuous | -9,557 | -2,836 | -5,422 | 1,681 | 8,610 |
| Minority Interests | -275 | -661 | -161 | -377 | -290 |
| Net Income | $-9,282 | $-2,175 | $-5,261 | $2,058 | $8,900 |
| EPS Basic Total Ops | -18.36 | -4.00 | -9.60 | 4.40 | 35.20 |
| EPS Basic Continuous Ops | -18.78 | -5.12 | -9.97 | 3.54 | 33.76 |
| EPS Diluted Total Ops | -18.36 | -4.00 | -9.60 | 4.40 | 35.20 |
| EPS Diluted Continuous Ops | -18.77 | -5.12 | -9.97 | 3.53 | 33.79 |
| EBITDA(a) | $-8,403 | $-8,014 | $-7,057 | $-4,781 | $8,039 |